Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients

Author： Lal Suman   Wong Zee Wan   Jada Srinivasa Rao   Xiang Xiaoqiang   Chen Shu Xiao   Ang Peter Cher Siang   Figg William D   Lee Edmund JD   Chowbay Balram  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.8, Iss.6, 2007-06, pp. : 567-575

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Population Pharmacokinetics and Pharmacodynamics of Doxorubicin and Cyclophosphamide in Breast Cancer Patients: A Study by the EORTC-PAMM-NDDG

By Joerger Markus   Huitema Alwin D.R.  

Clinical Pharmacokinetics, Vol. 46, Iss. 12, 2007-01 ,pp. : 1051-1068

Adis International

Access to resources Recommend Favorite

Effects of Esomeprazole on the Pharmacokinetics of Lapatinib in Breast Cancer Patients

By  

Clinical Pharmacology In Drug Development, Vol. 2, Iss. 4, 2013-10 ,pp. : 336-341

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population Pharmacokinetics of Sibrotuzumab, A Novel Therapeutic Monoclonal Antibody, in Cancer Patients

By Kloft C.   Graefe E-U.   Tanswell P.   Scott A. M.   Hofheinz R.   Amelsberg A.   Karlsson M. O.  

Investigational New Drugs, Vol. 22, Iss. 1, 2004-01 ,pp. : 39-52

Springer Publishing Company

Access to resources Recommend Favorite

Population Pharmacokinetics of Gemcitabine and Its Metabolite in Japanese Cancer Patients: Impact of Genetic Polymorphisms

By Sugiyama Emiko   Kaniwa Nahoko   Kim Su-Ryang  

Clinical Pharmacokinetics, Vol. 49, Iss. 8, 2010-08 ,pp. : 549-558

Adis International

Access to resources Recommend Favorite

Influence of Drug Transporter Polymorphisms on Pravastatin Pharmacokinetics in Humans

By Kivistö Kari   Niemi Mikko  

Pharmaceutical Research, Vol. 24, Iss. 2, 2007-02 ,pp. : 239-247

Springer Publishing Company

Access to resources Recommend Favorite